⌘K

18:20:55·164d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Rani Therapeutics Holdings Inc.

ByQuantisnow·Wall Street's wire, on your screen.

RANI· Rani Therapeutics Holdings Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

RANI
Rani Therapeutics Holdings Inc.
Health Care

Recent analyst ratings

Apr 14UpdateLake Street$9.00
Aug 2UpdateOppenheimer$17.00
Jun 14UpdateMaxim Group$15.00
Jun 13UpdateRodman & Renshaw$10.00
Apr 17UpdateBTIG Research$24.00
Oct 11UpdateUBS$15.00

Related

SEC12d
SEC Form DEFA14A filed by Rani Therapeutics Holdings Inc.
SEC12d
SEC Form DEF 14A filed by Rani Therapeutics Holdings Inc.
ANALYST14d
Lake Street initiated coverage on Rani Therapeutics with a new price target
PR19d
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
INSIDER31d
SEC Form 3 filed by new insider Javadi Alireza
SEC32d
Amendment: SEC Form SCHEDULE 13G/A filed by Rani Therapeutics Holdings Inc.
SEC33d
SEC Form S-8 filed by Rani Therapeutics Holdings Inc.
SEC33d
SEC Form 10-K filed by Rani Therapeutics Holdings Inc.